Home » Stocks » GNBT

Generex Biotechnology Corp. (GNBT)

Stock Price: $0.4750 USD 0.0250 (5.56%)
Updated Jan 26, 2021 3:57 PM EST - Market closed
Market Cap 50.21M
Revenue (ttm) 2.03M
Net Income (ttm) n/a
Shares Out 109.98M
EPS (ttm) -0.44
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 26
Last Price $0.4750
Previous Close $0.4500
Change ($) 0.0250
Change (%) 5.56%
Day's Open 0.4999
Day's Range 0.4550 - 0.4999
Day's Volume 679,639
52-Week Range 0.165 - 1.65

News

Hide News
  • All
  • Videos
  • Press Releases
GlobeNewsWire - 2 weeks ago

MIRAMAR, Fla., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) today announced that it will hold an investor conference call on Friday Februa...

GlobeNewsWire - 3 weeks ago

MIRAMAR, Fla., Dec. 31, 2020 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced that its majority...

GlobeNewsWire - 2 months ago

MIRAMAR, Fla., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) and subsidiary NuGenerex Immuno-O...

GlobeNewsWire - 2 months ago

MIRAMAR, Fla., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is pleased to announce that the c...

GlobeNewsWire - 2 months ago

MIRAMAR, Fla., Nov. 18, 2020 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is pleased to announce that the c...

GlobeNewsWire - 2 months ago

MIRAMAR, Fla., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced that the company ...

GlobeNewsWire - 2 months ago

MIRAMAR, Fla., Nov. 03, 2020 (GLOBE NEWSWIRE) -- NuGenerex Immuno-Oncology (NGIO), a subsidiary of Generex Biotechnology Corporation ( www.gen erex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.c...

Seeking Alpha - 2 months ago

Ii-Key technology is safe, and in a breast cancer trial 10 years out, still effective. GNBT is negotiating contracts covering these areas: Malaysia, New Zealand, Australia, Southeast Asia, Sin...

GlobeNewsWire - 2 months ago

-Dr. Tamera Coyne-Beasley, MD, MPH, FAAP, FSAHM is the Derrol Dawkins, MD Endowed Chair in Adolescent Medicine at Children's of Alabama, Professor of Pediatrics and Internal Medicine, Director...

GlobeNewsWire - 3 months ago

Exploring Essential Issues for Improving Therapeutic Cancer Vaccine Trial Design

GlobeNewsWire - 3 months ago

MIRAMAR, Fla., Oct. 07, 2020 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) today announced call-in details for tomorrow’s investor conference call on Thu...

GlobeNewsWire - 3 months ago

MIRAMAR, Fla., Oct. 07, 2020 (GLOBE NEWSWIRE) -- NuGenerex Immuno-Oncology (NGIO), a subsidiary of Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/s...

GlobeNewsWire - 3 months ago

MIRAMAR, Fla., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced that the company ...

GlobeNewsWire - 3 months ago

MIRAMAR, Fla., Oct. 02, 2020 (GLOBE NEWSWIRE) -- NuGenerex Immuno-Oncology (http://nugenerexio.com) is pleased to announce that the company will hold a shareholder conference call on Thursday ...

GlobeNewsWire - 4 months ago

-  NuGenHealth Software as a Service (SaaS) platform launch -  PVFM responds to COVID-19 with connected care solutions to serve their Medicare patient population

GlobeNewsWire - 4 months ago

MIRAMAR, Fla., Sept. 18, 2020 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) is pleased to announce tha...

Seeking Alpha - 4 months ago

Monoclonal Antibodies: A Good Place To Be In The Time Of Covid-19 And Stock Market Bubbles

Other stocks mentioned: BMY, CYDY, GILD, IMMU, INO, MESO, MRNA, NVAX, PFE, SRNE
GlobeNewsWire - 4 months ago

Article Published on September 8, 2020:

Seeking Alpha - 4 months ago

Generex Biotechnology's COVID-19 vaccine is potentially superior to leading competition.

About GNBT

Generex Biotechnology Corporation, through its subsidiaries, engages in the administration of formulations of large molecule drugs to the oral cavity using a hand-held aerosol applicator in Canada and the United States. It offers Generex Oral-lyn, an oral insulin product. The company is also developing AE37, a synthetic peptide vaccine, which has completed Phase IIb clinical trial to stimulate a potent and specific immune response against tumors expressing the HER-2/neu oncogene in patients with breast cancer and prostate cancer. In addition, i... [Read more...]

Industry
Biotechnology
Founded
1983
CEO
Joseph Moscato
Employees
15
Stock Exchange
OTCMKTS
Ticker Symbol
GNBT
Full Company Profile